The new COVID-19 strain known as “Arcturus” has increased in the U.S. so much that it has been added to the CDC’s watch list. Officially labeled XBB.1.16, Arcturus is a subvariant of Omicron that was first seen in India and has been on the World Health Organization’s watchlist since the […]
Federal regulators announced Tuesday that GlaxoSmithKline’s COVID-19 drug should no longer be used because it’s likely ineffective against BA.2, the Omicron subvariant that now accounts for most new cases in the U.S., the Associated Press reports. The FDA announced that the antibody drug sotrovimab is no longer authorized to treat patients in U.S. […]
Federal regulators have announced that GlaxoSmithKline’s COVID-19 drug should no longer be used because it’s likely ineffective against BA.2, the Omicron subvariant that now accounts for most new cases in the United States, The Associated Press reports. The Food and Drug Administration announced that the antibody drug sotrovimab is no longer authorized to […]
The percentage of Omicron subvariant BA.2 cases is rising in Los Angeles County, a trend seen elsewhere nationwide as officials sound the alarm about Congress’ failure to provide critical funding for vaccinations, tests and anti-COVID drugs. Officials in L.A. County and nationally have warned about the risk to public health […]
